Factors associated with false negative and false positive results of prostate-specific antigen (PSA) and the impact on patient health: Cohort study protocol

INTRODUCTION: Prostate-specific antigen (PSA) is the main tool for early detection, risk stratification and monitoring of prostate cancer (PCa). However, there are controversies about the use of PSA as a population screening test because of the high potential for overdiagnosis and overtreatment asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernal-Soriano, Mari Carmen, Parker, Lucy A., López-Garrigos, Maite, Hernández-Aguado, Ildefonso, Caballero-Romeu, Juan P., Gómez-Pérez, Luis, Alfayate-Guerra, Rocío, Pastor-Valero, María, García, Nuria, Lumbreras, Blanca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783167/
https://www.ncbi.nlm.nih.gov/pubmed/31577771
http://dx.doi.org/10.1097/MD.0000000000017451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783167/
https://www.ncbi.nlm.nih.gov/pubmed/31577771
http://dx.doi.org/10.1097/MD.0000000000017451

Ejemplares similares